Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Merus N.V. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Merus N.V. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 5,364 shares of MRUS stock, worth $505,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,364
Previous 6,101
12.08%
Holding current value
$505,020
Previous $256,000
10.16%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MRUS
# of Institutions
217Shares Held
65.3MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$403 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$377 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$351 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$332 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$319 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.32B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...